PF-3758309, p21-activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF-κB, and β-catenin signalings.
about
p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signalingIn silico identification of potential key regulatory factors in smoking-induced lung cancer.p21-Activated Kinase 4 Signaling Promotes Japanese Encephalitis Virus-Mediated Inflammation in Astrocytes.The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity.Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization.Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells.Chronic Cigarette Smoke Mediated Global Changes in Lung Mucoepidermoid Cells: A Phosphoproteomic Analysis.Prognostic significance of PAK4 expression in gastric cancer.The inhibitory effect of 7,7″-dimethoxyagastisflavone on the metastasis of melanoma cells via the suppression of F-actin polymerization.CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4.IDH-Inhibiting Small Molecule DTDQ Inhibits Migration and Invasion of A549 Human Non-Small-Cell Lung Cancer Cells via Sequential Inactivation Of ERK and P38 Signaling Pathways.Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion.
P2860
Q28269527-8055AB6B-7407-4566-A910-0CBE81DEF91DQ33776567-2A733DCA-A86A-4A1A-8809-90F3CC4B1221Q33819186-1E901AA2-6289-4CBD-85C3-B2275DB33A0AQ35662030-7D577C0F-0984-405C-940E-D2559130163FQ37588413-74E4C7C2-5D33-4134-BB9B-2058E9DCDD54Q37641586-91ECBC50-02DF-4515-BD86-19C6DB2E9899Q38694715-5972B142-E777-440D-B29C-ECEEB1044164Q41091136-D13869B2-8F50-471B-A1A7-F7212C60B9B0Q41694358-448BDA64-D47D-4E88-A255-2EC282E620E5Q47811348-FFA4361E-46CF-4810-BD76-7D9ACF0DF7A3Q48626677-34FA19D1-53F3-4F0E-A614-3CB080C3E4D0Q50952885-E7A7E052-A703-45DD-8B0C-4A36C105F4E5Q53061788-5B979E5F-AD7C-4C39-A38C-F973906809C2
P2860
PF-3758309, p21-activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF-κB, and β-catenin signalings.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
PF-3758309, p21-activated kina ...... -κB, and β-catenin signalings.
@en
PF-3758309, p21-activated kina ...... -κB, and β-catenin signalings.
@nl
type
label
PF-3758309, p21-activated kina ...... -κB, and β-catenin signalings.
@en
PF-3758309, p21-activated kina ...... -κB, and β-catenin signalings.
@nl
prefLabel
PF-3758309, p21-activated kina ...... -κB, and β-catenin signalings.
@en
PF-3758309, p21-activated kina ...... -κB, and β-catenin signalings.
@nl
P2093
P2860
P1476
PF-3758309, p21-activated kina ...... -κB, and β-catenin signalings.
@en
P2093
Byung Jun Ryu
Jeong-Tae Yeon
Jeongmin Lee
Jongsung Lee
Jung-Nyoung Heo
Sang Yeol Lee
Seong Hwan Kim
Seong-Ho Kim
Sik-Won Choi
P2860
P2888
P356
10.1007/S11010-013-1928-8
P50
P577
2013-12-24T00:00:00Z